TNF-α Induces a Pro-Inflammatory Phenotypic Shift in Monocytes through ACSL1: Relevance to Metabolic Inflammation.


Journal

Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
ISSN: 1421-9778
Titre abrégé: Cell Physiol Biochem
Pays: Germany
ID NLM: 9113221

Informations de publication

Date de publication:
2019
Historique:
received: 07 09 2018
accepted: 05 03 2019
entrez: 8 3 2019
pubmed: 8 3 2019
medline: 16 3 2019
Statut: ppublish

Résumé

TNF-α-mediated pro-inflammatory phenotypic change in monocytes is known to be implicated in the pathogenesis of metabolic inflammation and insulin resistance. However, the mechanism by which TNF-α-induces inflammatory phenotypic shift in monocytes is poorly understood. Since long-chain acyl-CoA synthetase 1 (ACSL1) is associated with inflammatory monocytes/macrophages, we investigated the role of ACSL1 in the TNF-α-driven inflammatory phenotypic shift in the monocytes. Monocytes (Human monocytic THP-1 cells) were stimulated with TNF-α. Inflammatory phenotypic markers (CD16, CD11b, CD11c and HLA-DR) expression was determined with real time RTPCR and flow cytometry. IL-1β and MCP-1 were determined by ELISA. Signaling pathways were identified by using ACSL1 inhibitor, ACSL1 siRNA and NF-κB reporter monocytic cells. Phosphorylation of NF-κB was analyzed by western blotting and flow cytometry. Our data show that TNF-α induced significant increase in the expression of CD16, CD11b, CD11c and HLA-DR. Inhibition of ACSL1 activity in the cells with triacsin C significantly suppressed the expression of these inflammatory markers. Using ACSL-1 siRNA, we further demonstrate that TNF-α-induced inflammatory markers expression in monocytic cells requires ACSL1. In addition, IL-1b and MCP-1 production by TNF-α activated monocytic cells was significantly blocked by the inhibition of ACSL-1 activity. Interestingly, elevated NF-κB activity resulting from TNF-α stimulation was attenuated in ACSL1 deficient cells. Our findings provide an evidence that TNF-α-associated inflammatory polarization in monocytes is an ACSL1 dependent process, which indicates its central role in TNF-α-driven metabolic inflammation.

Sections du résumé

BACKGROUND/AIMS OBJECTIVE
TNF-α-mediated pro-inflammatory phenotypic change in monocytes is known to be implicated in the pathogenesis of metabolic inflammation and insulin resistance. However, the mechanism by which TNF-α-induces inflammatory phenotypic shift in monocytes is poorly understood. Since long-chain acyl-CoA synthetase 1 (ACSL1) is associated with inflammatory monocytes/macrophages, we investigated the role of ACSL1 in the TNF-α-driven inflammatory phenotypic shift in the monocytes.
METHODS METHODS
Monocytes (Human monocytic THP-1 cells) were stimulated with TNF-α. Inflammatory phenotypic markers (CD16, CD11b, CD11c and HLA-DR) expression was determined with real time RTPCR and flow cytometry. IL-1β and MCP-1 were determined by ELISA. Signaling pathways were identified by using ACSL1 inhibitor, ACSL1 siRNA and NF-κB reporter monocytic cells. Phosphorylation of NF-κB was analyzed by western blotting and flow cytometry.
RESULTS RESULTS
Our data show that TNF-α induced significant increase in the expression of CD16, CD11b, CD11c and HLA-DR. Inhibition of ACSL1 activity in the cells with triacsin C significantly suppressed the expression of these inflammatory markers. Using ACSL-1 siRNA, we further demonstrate that TNF-α-induced inflammatory markers expression in monocytic cells requires ACSL1. In addition, IL-1b and MCP-1 production by TNF-α activated monocytic cells was significantly blocked by the inhibition of ACSL-1 activity. Interestingly, elevated NF-κB activity resulting from TNF-α stimulation was attenuated in ACSL1 deficient cells.
CONCLUSION CONCLUSIONS
Our findings provide an evidence that TNF-α-associated inflammatory polarization in monocytes is an ACSL1 dependent process, which indicates its central role in TNF-α-driven metabolic inflammation.

Identifiants

pubmed: 30845379
doi: 10.33594/000000028
doi:

Substances chimiques

CCL2 protein, human 0
Chemokine CCL2 0
HLA-DR Antigens 0
Interleukin-1beta 0
NF-kappa B 0
RNA, Small Interfering 0
Receptors, IgG 0
Triazenes 0
Tumor Necrosis Factor-alpha 0
triacsin C 6M6D4602I5
Coenzyme A Ligases EC 6.2.1.-
ACSL1 protein, human EC 6.2.1.3

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

397-407

Subventions

Organisme : Kuwait Foundation for Advancement of Sciences (KFAS)
ID : RC-14016001, RA-2013-002, RA AM 2016-007
Pays : Kuwait
Organisme : L'Oréal-UNESCO FWIS 2017 fellowship grant
Pays : France

Informations de copyright

© Copyright by the Author(s). Published by Cell Physiol Biochem Press.

Déclaration de conflit d'intérêts

The authors declare no conflict of interests.

Auteurs

Fatema Al-Rashed (F)

Immunology Unit, Dasman Diabetes Institute, Kuwait-City, Kuwait.

Zunair Ahmad (Z)

Immunology Unit, Dasman Diabetes Institute, Kuwait-City, Kuwait.
School of Medicine, Royal College of Surgeons in Ireland, Medical University of Bahrain, Busaiteen, Bahrain.

Mina Amin Iskandar (MA)

Immunology Unit, Dasman Diabetes Institute, Kuwait-City, Kuwait.
School of Medicine, Royal College of Surgeons in Ireland, Medical University of Bahrain, Busaiteen, Bahrain.

Jaakko Tuomilehto (J)

University of Helsinki, Helsinki, Finland.
Danube University Krems, Krems, Austria.

Fahd Al-Mulla (F)

Immunology Unit, Dasman Diabetes Institute, Kuwait-City, Kuwait.

Rasheed Ahmad (R)

Immunology Unit, Dasman Diabetes Institute, Kuwait-City, Kuwait, rasheed.ahmad@dasmaninstitute.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH